KFDA approved clinical trials on adult stem cell therapy.

Published: 2005-12-23 06:57:00

Updated: 2005-12-23 06:57:00

Sewon Cellontech announced that the KFDA approved their cellular therapy, Ostem, after differentiating stem cells into myeloblasts on Dec. 19, which will be the first commercialized case in the world.

The previous studies reported to make osteocytes by differentiating adult stem cells isolate...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK